Close Menu

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Monday that its third quarter revenues fell 3 percent, with Chairman and CEO Robert Friel blaming "challenging market conditions" for the drop.

For the three months ended Oct. 2, the company said revenues fell to $548.1 million from $563.4 million in Q3 2015, widely missing Wall Street analysts' average estimate of $572.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.